The IACM conference in Berlin highlighted talks from the top professionals in the field of cannabis science. Christine Milentis, our Executive Secretary, reports on the history of cannabis for medical use and the rights of doctors across the globe to prescribe it.
Sometimes practitioners feel like they can’t recommend cannabis due to legal limitations, stigma, or a lack of support. Dr. Sarah Mann tells the tale of one of her patients who inspired the shift towards a cannabis integrated practice.
Kevin M. Takakuwa, MD and Dr. Dustin Sulak evaluate how US medical professionals received their cannabis medicine training in Mary Ann Liebert, Inc.
Genester Wilson-King, MD and Dr. Michael Eisenberg are conducting research on cannabis and sexual health at Stanford University. The survey will provide an opportunity for the general public to participate in cannabis research.
SCC member Kevin M. Takakuwa, MD outlines on the historical impact of cannabis and its relevance to pediatric practice. The article highlights how cannabis may benefit seizure disorders in children and young adults.
During Pride Month, we owe it to history to recall an embarrassing, tragic twist in the relationship between AIDS activism and the medical marijuana movement.
The historical account of Dennis Peron, the medical cannabis and human rights activist who was instrumental in bringing attention to AIDS and changing cannabis policy in California.
Findings suggest that CBD may have therapeutic potential to reduce binge eating and the development of obesity, according to a paper published by Addiction Biology.
On June 19 the House of Representatives voted to add the Blumenauer-McClintock Amendment —which would prevent the Department of Justice from enforcing federal law in states that have legalized adult-use marijuana—to an appropriations bill.